Business Wire

MINISTER-HAJJ-UMRAH

11.1.2023 13:04:35 CET | Business Wire | Press release

Share
Hajj Expo 2023 Kicks Off, Under the Patronage of Makkah Governor

H.R.H Prince Khaled Al-Faisal, Advisor to the Custodian of the Two Holy Mosques and Governor of Makkah Region, and H.R.H Prince Faisal bin Salman bin Abdulaziz Al Saud, Governor, Madinah Province inaugurated the 2023 conference and exhibition on Hajj and Umrah ‘Hajj Expo’. Held in Jeddah, the second edition of Hajj Expo featured 81 speakers from public and private sectors, as well as high-level delegations of ministers of religious affairs, heads of Hajj missions and higher authorities from +57 countries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230111005423/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

H.R.H Prince Khaled Al-Faisal, Advisor to the Custodian of the Two Holy Mosques and Governor of Makkah Region touring the exhibition with H.E. Minister of Hajj and Umrah, Dr. Tawfiq bin Fawzan Al-Rabiah (Photo: AETOSWire)

H.E. Minister of Hajj and Umrah, Dr. Tawfiq bin Fawzan Al-Rabiah welcomed the esteemed guests, noting that Saudi Arabia’s top priority is to ensure that pilgrims can perform Hajj and Umrah safely and securely by enhancing the digital capabilities of services. “This is a historical commitment and an honor to be proud of for the Two Holy Mosques government,” he said.

Al-Rabiah reiterated the Ministry’s keenness to enrich the Hajj and Umrah experience by developing services and solutions and introducing enhanced regulations and procedures. He praised the commitment of relevant authorities and the early signing of Hajj agreements as ‘testament to the unrelenting keenness to provide better services to pilgrims and Umrah performers.’

The event witnessed several agreements and MoUs between key entities, notably the General Authority for Awqaf (GAA), the Saudi Conventions and Exhibitions General Authority (SCEGA), the King Salman Global Academy for Arabic Language (KSAA), the Saudi Standards, Metrology and Quality Organization (SASO) and the Media and Banking Awareness Committee for Saudi Banks. More than 57 Hajj service agreements were also signed, regarding Hajj pilgrim numbers, dedicated plans for the arrival of pilgrims, and health requirements and procedural instructions.

Hajj Expo discussed ways to enhance quality of Hajj services in 10 keynote sessions, 13 panel discussions and ‘Hajj Talks’, as well as 36 workshops and other events and activities: the Islamic exposition, the Hajj and Umrah Challenge Area, and the Startup Zone.

Hajj Expo aims at building an integrated and sustainable ecosystem of services and solutions to enhance the experience of pilgrims, anticipate future directions and establish opportunities for further collaborations, agreements, and local and international initiatives, while showcasing Saudi Arabia’s efforts to enhance the sustainable development of pilgrim services.

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230111005423/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pacific Defense Awarded U.S. Marine Corps Contract for Next Generation Electronic Warfare Prototype29.4.2026 13:00:00 CEST | Press release

Award advances SOSA/CMOSS mission system ecosystem and informs future EW fielding decisions Pacific Defense has been awarded a 12-month rapid prototyping contract by the U.S. Marine Corps Systems Command (MARCORSYSCOM), Program Manager for Tactical Communications and Electronic Warfare (PM TCE) to support next-generation electronic warfare (EW) capability evaluation. The effort will assess Modular Open Systems Approach (MOSA) Electronic Warfare (EW) mission systems and their potential in modernizing USMC capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429918712/en/ Pacific Defense's Next Generation Electronic Warfare System enables rapid integration of new hardware and software into a common chassis, accelerating capability insertion while reducing vendor lock and lifecycle costs. Under the contract, Pacific Defense will deliver SOSA/CMOSS-aligned mission systems to enable vehicle-based experimentation by U.S

Visa Accelerates Stablecoin Momentum: Adding Five Blockchains for Settlement29.4.2026 13:00:00 CEST | Press release

Stablecoin settlement pilot sees record growth 50% quarter over quarter, reaching $7B run rate. Today, Visa (NYSE: V) announced that it is adding five blockchains to its global stablecoin settlement pilot, expanding how issuers and acquirers can settle with the network. As stablecoins move into mainstream payment flows, Visa’s stablecoin settlement pilot now supports nine blockchains and has reached a $7 billion annualized stablecoin settlement run rate, up 50% since last quarter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429143049/en/ Visa is adding support for five additional blockchains, further expanding its multi-chain settlement capabilities. “Our partners are building in a multi-chain world, and they expect their options to reflect that reality,” said Rubail Birwadker, Global Head of Growth Products and Strategic Partnerships, Visa. “Expanding our stablecoin settlement pilot program to more blockchains means o

U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release

TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica

European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt

Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release

OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye